Archive for category: Healthcare

EPISURF MEDICAL OBTAINS FURTHER GRANTED PATENT IN EUROPE

EPISURF MEDICAL OBTAINS FURTHER GRANTED PATENT IN EUROPE

/ June 13, 2017 8:58 am

The European patent office EPO has announced its intention to grant another European patent for Episurf Medical. The patent Implant specific drill bit comprises one of the tools in Episurf Medical’s kit with surgical instruments used for implantation of the […]

Rosetta Genomics Granted European Patent Allowance Covering RosettaGX Cancer Origin Assay

Rosetta Genomics Granted European Patent Allowance Covering RosettaGX Cancer Origin Assay

/ May 26, 2017 8:09 am

Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, announces that the European Patent Office has granted a patent allowance for European patent application No. 11842532.1, titled […]

Prescient Therapeutics granted European patent for its cancer therapy

Prescient Therapeutics granted European patent for its cancer therapy

/ May 17, 2017 8:04 am

Clinical-stage oncology company Prescient Therapeutics Ltd (ASX: PTX) is pleased to announce that a new patent has been granted in Europe providing platform technology protection for its lead clinical compound PTX-200 (triciribine phosphate). The patent “Effective treatment of tumors and […]

Rosetta Genomics Expands Patent Portfolio in Europe and Japan

Rosetta Genomics Expands Patent Portfolio in Europe and Japan

/ May 10, 2017 8:20 am

Granted European Patent Allowance and Japanese Patent for microRNA-based Lung Cancer Classifier Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, announces that the European Patent Office […]

CEL-SCI RECEIVES INTENT TO GRANT NOTICE FOR NEW MULTIKINE PATENT FROM THE EUROPEAN PATENT OFFICE

CEL-SCI RECEIVES INTENT TO GRANT NOTICE FOR NEW MULTIKINE PATENT FROM THE EUROPEAN PATENT OFFICE

/ May 5, 2017 8:12 am

 CEL-SCI Corporation (NYSE MKT: CVM) today announced that it has been notified that it will be granted a new patent on Multikine* (Leukocyte Interleukin, Injection), its investigational cancer immunotherapy, from the European Patent Office. The patent is titled: A METHOD FOR MODULATING HLA […]

ORAMED GRANTED EUROPEAN PATENT FOR COMBINATION ORAL INSULIN AND GLP-1 ANALOG CAPSULE

ORAMED GRANTED EUROPEAN PATENT FOR COMBINATION ORAL INSULIN AND GLP-1 ANALOG CAPSULE

/ May 5, 2017 8:02 am

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the European Patent Office has granted the Company a patent titled, “Methods and Compositions for Treating Diabetes: Capsules containing […]

VistaGen Therapeutics Receives European Patent Office Notice of Intention to Grant European Patent for AV-101

VistaGen Therapeutics Receives European Patent Office Notice of Intention to Grant European Patent for AV-101

/ April 12, 2017 8:18 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) disorders, announced today that the European Patent Office (EPO) has issued a Notice of Intention to Grant the […]

European Patent Office to grant UC a broad patent on CRISPR-Cas9

European Patent Office to grant UC a broad patent on CRISPR-Cas9

/ March 29, 2017 8:03 am

The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S. The European Patent Office (EPO) yesterday (March 23) announced its […]

Pulmatrix Receives European Patent for its Inhaled Drug Delivery Technology

Pulmatrix Receives European Patent for its Inhaled Drug Delivery Technology

/ March 24, 2017 9:02 am

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, today announced that it has received a key patent from the European Union. “This new patent shows our continued ability to obtain […]

European Patent Granted for OsteoFab® Implants

European Patent Granted for OsteoFab® Implants

/ March 16, 2017 8:52 am

SOUTH WINDSOR, Conn., March 13, 2017 (GLOBE NEWSWIRE) — Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced that it has received a Notice of Decision to Grant a Patent […]